Nippon India Multi Asset Allocation Fund
Mankind Pharma Limited · NSE
2,55,532 sh · ₹63.11 Cr
SBI Large Cap Fund
1.8% of their portfolio
₹1,005.85 Cr
40,72,930 sh
Nippon India Growth Mid Cap Fund
1.7% of their portfolio
₹856.95 Cr
34,70,011 sh
HDFC Large Cap Fund
1.7% of their portfolio
₹676.54 Cr
27,39,492 sh
Nippon India Large Cap Fund
0.8% of their portfolio
₹430.70 Cr
17,43,999 sh
Aditya Birla Sun Life Flexi Cap Fund
1.6% of their portfolio
₹423.80 Cr
16,64,835 sh
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
5.5% of their portfolio
₹372.19 Cr
15,07,093 sh
Nippon India Pharma Fund
3.7% of their portfolio
₹346.84 Cr
14,04,429 sh
SBI Contra Fund
68.0% of their portfolio
₹327.97 Cr
13,28,039 sh
Aditya Birla Sun Life Large Cap Fund
1.1% of their portfolio
₹321.37 Cr
12,62,461 sh
Nippon India Flexi Cap Fund
1.8% of their portfolio
₹170.01 Cr
6,88,395 sh
Nippon India ELSS Tax Saver Fund
1.1% of their portfolio
₹157.81 Cr
6,39,000 sh
SBI Healthcare Opportunities Fund
1.8% of their portfolio
₹98.78 Cr
4,00,000 sh
FIIs trimmed their stake −0.8pp QoQ
Jun 2026 quarter
Ownership by quarter
Promoter
— 0.0pp
Nippon India Multi Asset Allocation Fund
Mankind Pharma Limited · NSE
2,55,532 sh · ₹63.11 Cr
HDFC Nifty LargeMidcap 250 Index Fund
Mankind Pharma Limited · NSE
6,187 sh · ₹1.53 Cr
SBI Contra Fund
Mankind Pharma Limited · NSE
13,28,039 sh · ₹327.97 Cr
Groww Mutual Fund (scheme 2E)
Mankind Pharma Limited · NSE
108 sh · ₹2.67 L
ICICI Prudential BSE 500 ETF
Mankind Pharma Limited · NSE
2,048 sh · ₹50.58 L
Groww Mutual Fund (scheme YD)
Mankind Pharma Limited · NSE
403 sh · ₹9.95 L
SBI Large Cap Fund
Mankind Pharma Limited · NSE
40,72,930 sh · ₹1,005.85 Cr
SBI Healthcare Opportunities Fund
Mankind Pharma Limited · NSE
4,00,000 sh · ₹98.78 Cr
SBI Nifty Midcap 150 Index Fund
Mankind Pharma Limited · NSE
32,856 sh · ₹8.11 Cr
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
42 announcements on record for this company.
Nippon India Balanced Advantage Fund
0.3% of their portfolio
₹24.70 Cr
1,00,000 sh
Promoter holding by quarter: Jun 2025 72.7%, Sep 2025 72.7%, Dec 2025 72.7%, Mar 2026 72.7%. Dec 2024, Mar 2025: no filing.
FII
— −1.1pp
FII holding by quarter: Jun 2025 13.1%, Sep 2025 12.8%, Dec 2025 11.3%, Mar 2026 10.2%. Dec 2024, Mar 2025: no filing.
DII
— +1.2pp
DII holding by quarter: Jun 2025 11.5%, Sep 2025 11.9%, Dec 2025 13.3%, Mar 2026 14.5%. Dec 2024, Mar 2025: no filing.
MF
— +1.1pp
MF holding by quarter: Jun 2025 7.3%, Sep 2025 7.8%, Dec 2025 9.3%, Mar 2026 10.4%. Dec 2024, Mar 2025: no filing.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
Nippon India ETF Nifty Midcap 150
Mankind Pharma Limited · NSE
1,01,576 sh · ₹25.09 Cr
Ownership by quarter
Promoter
— 0.0pp
Promoter holding by quarter: Jun 2025 72.7%, Sep 2025 72.7%, Dec 2025 72.7%, Mar 2026 72.7%. Dec 2024, Mar 2025: no filing.
FII
— −1.1pp
FII holding by quarter: Jun 2025 13.1%, Sep 2025 12.8%, Dec 2025 11.3%, Mar 2026 10.2%. Dec 2024, Mar 2025: no filing.
DII
— +1.2pp
DII holding by quarter: Jun 2025 11.5%, Sep 2025 11.9%, Dec 2025 13.3%, Mar 2026 14.5%. Dec 2024, Mar 2025: no filing.
MF
— +1.1pp
MF holding by quarter: Jun 2025 7.3%, Sep 2025 7.8%, Dec 2025 9.3%, Mar 2026 10.4%. Dec 2024, Mar 2025: no filing.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
42 announcements on record for this company.